Literature DB >> 18201725

The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer's disease in Chinese.

Binbin Wang1, Jing Wang, Sirui Zhou, Sainan Tan, Xiang He, Ze Yang, Yan-Chen Xie, Shu Li, Chenguang Zheng, Xu Ma.   

Abstract

A functional polymorphism of mitochondrial aldehyde dehydrogenase gene (ALDH2 1/2 polymorphism) can influence the accumulation of acetaldehyde which may have a role in Alzheimer's disease (AD), and is widely prevalent among Mongoloids. Therefore ALDH2 1/2 polymorphism may represent a good candidate for genetic risk factors for AD, especially in East Asian. A case-control study from Japan found that ALDH2*2 was associated with late-onset AD (LOAD), interacting synergistically with the presence of the apolipoprotein E allele 4 (APOE epsilon4). But the subsequent studies in Koreans didn't find the similar result. To determine whether the ALDH2 gene 1/2 polymorphism contributes to the risk for LOAD in Chinese, we have investigated 188 sporadic LOAD patients and 223 healthy controls from Chinese. A significantly increased risk of AD in the carriers of ALDH2*2 allele (OR=3.11, 95% CI 2.06-4.69, P<0.001) was observed. After stratifying by APOE epsilon4 status, increased LOAD risks associated with the ALDH2 2 allele carriers only in the APOE epsilon4 non-carriers (chi2=31.79, df=1, P<0.001) and with the 2-allele in either groups (chi2=6.64 df=1, P=0.0099 and chi2=37.38, df=1, P<0.001) were seen. These results suggested that the ALDH2 gene 1/2 polymorphism might be a risk factor for LOAD and dependent on APOE epsilon4 status in Chinese.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201725     DOI: 10.1016/j.jns.2007.12.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  26 in total

1.  Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease.

Authors:  Miwa Komatsu; Nobuto Shibata; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Aiko Toda; Yuko Tagata; Tomoko Nakada; Hiromi Shimazaki; Heii Arai
Journal:  J Neural Transm (Vienna)       Date:  2013-11-08       Impact factor: 3.575

2.  Accumulated hippocampal formaldehyde induces age-dependent memory decline.

Authors:  Zhiqian Tong; Chanshuai Han; Wenhong Luo; Xiaohui Wang; Hui Li; Hongjun Luo; Jiangning Zhou; Jinshun Qi; Rongqiao He
Journal:  Age (Dordr)       Date:  2012-03-03

3.  Overexpression of aldehyde dehydrogenase-2 attenuates neurotoxicity induced by 4-hydroxynonenal in cultured primary hippocampal neurons.

Authors:  Jing Bai; Yuanwu Mei
Journal:  Neurotox Res       Date:  2010-04-02       Impact factor: 3.911

4.  Different Effects of Knockouts in ALDH2 and ACSS2 on Embryonic Stem Cell Differentiation.

Authors:  Ryan N Serio; Changyuan Lu; Steven S Gross; Lorraine J Gudas
Journal:  Alcohol Clin Exp Res       Date:  2019-08-05       Impact factor: 3.455

Review 5.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

6.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

Review 7.  A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant.

Authors:  Eric R Gross; Vanessa O Zambelli; Bryce A Small; Julio C B Ferreira; Che-Hong Chen; Daria Mochly-Rosen
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-29       Impact factor: 13.820

8.  Drosophila lacking a homologue of mammalian ALDH2 have multiple fitness defects.

Authors:  Mahul Chakraborty; James D Fry
Journal:  Chem Biol Interact       Date:  2011-02-04       Impact factor: 5.192

Review 9.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

10.  Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease.

Authors:  Ahmed Elharram; Nicole M Czegledy; Michael Golod; Ginger L Milne; Erik Pollock; Brian M Bennett; Mikhail S Shchepinov
Journal:  FEBS J       Date:  2017-10-27       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.